Herbal formulations in oral submucous fibrosis treatment – A narrative review

Sahana Shivakumar, GanigaChannaiah Shivakumar
{"title":"Herbal formulations in oral submucous fibrosis treatment – A narrative review","authors":"Sahana Shivakumar, GanigaChannaiah Shivakumar","doi":"10.4103/jpo.jpo_15_23","DOIUrl":null,"url":null,"abstract":"This narrative review provides an overview of the use of herbal formulations in the treatment of oral submucous fibrosis (OSMF). OSMF is a potentially malignant disorder characterized by progressive fibrosis of the oral mucosa, resulting in restricted mouth opening and other debilitating symptoms. Conventional treatment options for OSMF are limited, and their effectiveness varies. Herbal formulations have gained attention as alternative and complementary treatment options for OSMF due to their perceived natural origin, minimal side effects, and potential therapeutic effects. These formulations typically consist of plant-derived ingredients with bioactive compounds that possess anti-inflammatory, antioxidant, antifibrotic, and immunomodulatory properties. Various herbal ingredients, such as Aloe vera, curcumin, licorice, honey, and triphala, have been investigated for their potential efficacy in OSMF treatment. These ingredients have shown promise in targeting the underlying mechanisms involved in OSMF pathogenesis, including inflammation, fibrosis, oxidative stress, and immune dysregulation. Herbal formulations offer potential advantages in OSMF treatment. They may provide a holistic approach by addressing multiple aspects of the disease and promoting overall oral health. Herbal formulations also have the advantage of cultural acceptability and cost-effectiveness. To further advance our understanding of herbal formulations in OSMF treatment, well-designed clinical trials with standardized protocols and larger sample sizes are needed. In addition, the development of evidence-based guidelines for the use of herbal formulations in OSMF would aid health-care professionals in making informed treatment decisions. Herbal formulations have shown promise as potential treatment options for OSMF. While their efficacy and safety need further investigation, they offer a natural and holistic approach to OSMF management. Collaboration between researchers, clinicians, and regulatory bodies is essential to advance the research and ensure the safe and effective use of herbal formulations in OSMF treatment.","PeriodicalId":16081,"journal":{"name":"Journal of Immunotherapy and Precision Oncology","volume":"90 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Immunotherapy and Precision Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jpo.jpo_15_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

This narrative review provides an overview of the use of herbal formulations in the treatment of oral submucous fibrosis (OSMF). OSMF is a potentially malignant disorder characterized by progressive fibrosis of the oral mucosa, resulting in restricted mouth opening and other debilitating symptoms. Conventional treatment options for OSMF are limited, and their effectiveness varies. Herbal formulations have gained attention as alternative and complementary treatment options for OSMF due to their perceived natural origin, minimal side effects, and potential therapeutic effects. These formulations typically consist of plant-derived ingredients with bioactive compounds that possess anti-inflammatory, antioxidant, antifibrotic, and immunomodulatory properties. Various herbal ingredients, such as Aloe vera, curcumin, licorice, honey, and triphala, have been investigated for their potential efficacy in OSMF treatment. These ingredients have shown promise in targeting the underlying mechanisms involved in OSMF pathogenesis, including inflammation, fibrosis, oxidative stress, and immune dysregulation. Herbal formulations offer potential advantages in OSMF treatment. They may provide a holistic approach by addressing multiple aspects of the disease and promoting overall oral health. Herbal formulations also have the advantage of cultural acceptability and cost-effectiveness. To further advance our understanding of herbal formulations in OSMF treatment, well-designed clinical trials with standardized protocols and larger sample sizes are needed. In addition, the development of evidence-based guidelines for the use of herbal formulations in OSMF would aid health-care professionals in making informed treatment decisions. Herbal formulations have shown promise as potential treatment options for OSMF. While their efficacy and safety need further investigation, they offer a natural and holistic approach to OSMF management. Collaboration between researchers, clinicians, and regulatory bodies is essential to advance the research and ensure the safe and effective use of herbal formulations in OSMF treatment.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
口腔黏膜下纤维化的中药治疗综述
这篇叙述性的综述提供了在治疗口腔粘膜下纤维化(OSMF)中使用草药配方的概述。OSMF是一种潜在的恶性疾病,其特征是口腔黏膜进行性纤维化,导致张嘴受限和其他衰弱症状。OSMF的常规治疗选择是有限的,其有效性也各不相同。草药制剂由于其天然来源、副作用最小和潜在的治疗效果,作为OSMF的替代和补充治疗选择而受到关注。这些配方通常由具有抗炎、抗氧化、抗纤维化和免疫调节特性的生物活性化合物的植物源性成分组成。各种草药成分,如芦荟、姜黄素、甘草、蜂蜜和triphala,已被研究其治疗OSMF的潜在功效。这些成分有望靶向OSMF发病机制的潜在机制,包括炎症、纤维化、氧化应激和免疫失调。草药制剂在OSMF治疗中具有潜在的优势。他们可以通过解决疾病的多个方面和促进整体口腔健康提供一个整体的方法。草药配方还具有文化可接受性和成本效益的优势。为了进一步加深我们对草药配方在OSMF治疗中的理解,需要设计良好的临床试验,采用标准化的方案和更大的样本量。此外,制定在OSMF中使用草药配方的循证准则将有助于保健专业人员作出知情的治疗决定。草药制剂已显示出作为OSMF潜在治疗选择的希望。虽然它们的有效性和安全性需要进一步调查,但它们为OSMF管理提供了一种自然而全面的方法。研究人员、临床医生和监管机构之间的合作对于推进研究和确保在OSMF治疗中安全有效地使用草药配方至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.40
自引率
0.00%
发文量
17
期刊最新文献
Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I Trial. Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma: An Open-Label, Phase 1 Study. Selinexor (KPT-330) in Combination with Immune Checkpoint Inhibition in Uveal Melanoma: A Phase 1B Trial. Expert Clinical Management of Inflammatory Immune-Related Arthritis in Patients with Cancer Receiving Immune Checkpoint Inhibitors. Usefulness of Comprehensive Genomic Profiling in Clinical Decision-Making in Oncology: A Systematic Review.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1